Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits

Nitric Oxide : Biology and Chemistry
Filomena De NigrisClaudio Napoli

Abstract

Nitric oxide (NO) exerts a plethora of vascular beneficial effects. The NO-releasing beta-blocker nebivolol is a racemic mixture of D/L-enantiomers that displays negative inotropic as well as direct vasodilating activity. The in vivo antiatherogenic activity of therapeutic doses of the beta-blocker with antioxidant properties carvedilol (12.5mg/day) or nebivolol (5mg/day) was tested in cholesterol-fed rabbits. Animals received a 1% cholesterol-rich diet alone (controls) or mixed with drugs (treated animals) for 8 weeks. While it did not affect hyperlipidemia, nebivolol inhibited the development of atherosclerosis, expressed as computer-assisted imaging analysis of aortic area covered by lesions (23.3+/-4.1% in treated vs 38.2+/-6.4% in control animals, p<0.01). Differently, in our experimental condition of therapeutic drug doses, this antiatherogenic effect did not reach statistical significance in rabbits treated with carvedilol (32.5+/-5.1% aortic area covered by lesions, p=NS vs controls). Plasma nitrates increased in rabbits treated with nebivolol while both beta-blockers reduced LDL oxidation. Moreover, nebivolol induced a consistent increase of endothelial reactivity and aortic eNOS expression compared with control animal...Continue Reading

References

Jan 11, 1991·Fundamental & Clinical Pharmacology·A J NicholsR R Ruffolo
Jan 11, 1990·European Journal of Clinical Pharmacology·R R RuffoloA J Nichols
Oct 1, 1995·Atherosclerosis·J FruebisW Palinski
Jan 1, 1997·Pharmacology·G Z FeuersteinR R Ruffolo
Nov 22, 1997·Stroke; a Journal of Cerebral Circulation·C NapoliD D Heistad
Dec 22, 1999·Journal of Cardiovascular Pharmacology·L J IgnarroC Napoli
Apr 9, 2001·Nitric Oxide : Biology and Chemistry·C Napoli, L J Ignarro
Sep 12, 2002·Nitric Oxide : Biology and Chemistry·Louis J IgnarroGeorgette M Buga
Jul 9, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G Cirino
Aug 21, 2003·Trends in Molecular Medicine·Filomena de NigrisClaudio Napoli
Dec 4, 2003·Journal of the American College of Cardiology·Luciano CominaciniVincenzo Lo Cascio
Dec 12, 2003·Journal of Cardiovascular Pharmacology·Annemieke A de GrootStephan L M Peters
Jul 21, 2004·Hypertension·Carmel M McEnieryJohn R Cockcroft
Oct 14, 2004·Journal of Hypertension·Maurizio GalderisiGiovanni de Simone
Jul 21, 2005·Current Medicinal Chemistry·C NapoliF de Nigris
May 11, 2006·Nitric Oxide : Biology and Chemistry·Claudio NapoliLouis J Ignarro
Jan 20, 2007·Cardiovascular Drugs and Therapy·Mario TogniOtto M Hess
Feb 7, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stefano EvangelistaLuciano Cominacini
Apr 10, 2007·Cardiovascular Drugs and Therapy·Eli I Lev, Alexander Battler
Feb 22, 2008·Journal of Cardiovascular Pharmacology·Osvaldo MasoliLuis Vidal Md
Feb 29, 2008·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Luc M Van BortelFlavio Mascagni

❮ Previous
Next ❯

Citations

Aug 23, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Natasha C MoningkaChris Baylis
Feb 2, 2011·Journal of Cardiovascular Pharmacology·Yuansheng Gao, Paul M Vanhoutte
May 7, 2009·Current Opinion in Cardiology·Michala E Pedersen, John R Cockcroft
Sep 22, 2012·Journal of the American Society of Hypertension : JASH·Dinko SusicEdward D Frohlich
Apr 23, 2014·The Canadian Journal of Cardiology·Jonathan G Howlett
Jan 9, 2013·Current Opinion in Pharmacology·Paul M Vanhoutte, Yuansheng Gao
Mar 23, 2012·Postgraduate Medicine·Hassan FaresHector O Ventura
Oct 10, 2009·Journal of the American College of Cardiology·Thomas Münzel, Tommaso Gori
May 15, 2013·Journal of the American College of Cardiology·Claudio NapoliLouis J Ignarro
May 16, 2009·Therapeutic Advances in Cardiovascular Disease·Angelo Maffei, Giuseppe Lembo
Jan 23, 2021·Angiology·Teresa InfanteClaudio Napoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.